Reports: Legislative

July 18, 2024
A public health emegerncy (PHE) was declared on March 11, 2020, due to COVID-19. This PHE provided the Louisiana Department of Health (LDH) with the authority to expand the list of provider types that can order home health services to include nurse practitioners, clinical nurse specialists, and physician assistants. Act 181, passed in the 2021 Regular Session, promulgated the expansion of providers that LDH was already allowing to order home health services due to the PHE. The claim and encounter data shows an increase in overall utilization of home health services. However, due to the disruption to the healthcare system caused by the COVID pandemic, it is not currently feasible to isolate specific impacts of Act 181.
July 02, 2024
SB 689 of the 2004 Regular Session and HB 369 of the 2005 Regular Session required DHH to provide an annual written report to the governor and to the legislature regarding the cost of administering the preferred drug list, including the cost of administering the prior authorization function, the costs of development and maintenance of the preferred drug list and aggregate funds returned to the federal government related to pharmaceutical rebates, and an analysis of the utilization trends for medical services provided by the state and any correlation to the preferred drug list.
May 14, 2024
The Louisiana Children’s Health Insurance Program (LaCHIP) is an optional Medicaid program that provides healthcare coverage to uninsured children up to age 19 and enrollees in the LaCHIP Unborn Option (Phase IV) which provides prenatal care services, from conception to birth, for low income uninsured mothers who are not otherwise eligible for Medicaid.
May 14, 2024
LDH is required to publish a quarterly report containing data directly related to payment for health care services through the implementation of a health coverage expansion of the Louisiana medical assistance program, in addition to directed payments and other supplemental payments made to hospitals.
May 14, 2024
This report is submitted pursuant to Senate Bill 298 of the 2022 Regular Legislative Session, which requires the Louisiana Department of Health (LDH) to conduct an annual review of all medications and forms of treatment for sickle cell disease (SCD) that are eligible for coverage under the Louisiana Medicaid program.
April 15, 2024
In 1995, the Louisiana Legislature passed Act 985, which required that the Louisiana Department of Health (LDH) prepare a yearly report card describing the overall health of its citizens and health‐related issues affecting Louisianans. In addition to informing Louisianans of the overall health circumstances in our state, this annual publication is an effective tool for health planning and evaluating the effectiveness of health programs.
Accessibility